<DOC>
	<DOCNO>NCT01725308</DOCNO>
	<brief_summary>In period I , treatment effect FK949E compare placebo blind manner bipolar disorder patient major depressive episode . In period II , long-term safety efficacy FK949E evaluate .</brief_summary>
	<brief_title>A Study Evaluate Efficacy FK949E Bipolar Disorder Patients With Major Depressive Episodes</brief_title>
	<detailed_description>This study consist two part . In Treatment Period I , FK949E placebo administer orally blind manner bipolar disorder patient major depressive episode , aim evaluate superiority FK949 placebo dose response two dos FK949E base change Montgomery-Asberg Depression Rating Scale ( MADRS ) total score . In Treatment Period II , long-term safety , efficacy pharmacokinetics FK949E evaluate patient complete Treatment Period I . Results report Treatment Period I .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Diagnosis bipolar I II disorder specify Diagnostic Statistical Manual Mental Disorders Ver . 4 Text Revision ( DSMIVTR , ) major depressive episode The Hamilton Depression Rating Scale ( HAMD17 ) total score 20 point HAMD17 depress mood score 2 point Able participate study understand compliance subject requirement study investigator 's subinvestigator 's opinion Concurrent previous history DSMIVTR Axis I disorder , except bipolar disorder , within last 6 month inform consent Concurrence DSMIVTR Axis II disorder consider greatly affect patient 's current mental status The Young Mania Rating Scale ( YMRS ) total score 13 point Nine mood episode within last 12 month inform consent Lack response least 6week treatment least 2 antidepressant current major depressive episode investigator 's subinvestigator 's opinion History abuse dependence alcohol substance caffeine nicotine Treatment depot antipsychotic within last 42 day primary registration Unable stop take mood stabilizer ( lithium carbonate and/or sodium valproate ) , lamotrigine , antipsychotic , antidepressant 7 day secondary registration Unable stop take antiepileptic ( except lamotrigine sodium valproate ) , antianxiety agent , hypnotic , sedative , psychostimulants , antiparkinsonian agent , cerebral ameliorators , antidementia agent , anorectic , except specify conditionallyallowed concomitant drug , primary registration Electroconvulsive therapy within last 76 day primary registration The current major depressive episode persist 12 month less 4 week inform consent A possible need psychotherapy study period ( unless therapy commence least 76 day primary registration maintain fix level fix frequency ) Documented suspected condition renal failure , hepatic failure , serious cardiac disease , hepatitis B , hepatitis C , acquire immunodeficiency syndrome ( AIDS ) ( carrier hepatitis B , hepatitis C , AIDS ) Concurrence malignancy history cure malignancy within 5 year Concurrence uncontrolled hypertension ( define systolic blood pressure 180 mmHg , diastolic blood pressure 110 mmHg primary registration ) unstable angina may worsen study may affect study result base clinical judgment investigator subinvestigator Concurrence hypotension ( define systolic blood pressure le 100 mmHg primary registration ) orthostatic hypotension History transient , idiopathic orthostatic hypotension , without presyncope symptom syncope , current condition susceptible transient hypotension , dehydration decrease blood volume Concurrent previous history cerebrovascular disease transient ischemic attack ( TIA ) Abnormal laboratory electrocardiographic finding consider clinically significant investigator 's subinvestigator 's opinion ( reference grade 3 Adverse Drug Reactions Severity Grading Criteria [ Notification No . 80 Safety Division , Pharmaceutical Affairs Bureau , Ministry Health Welfare date 29 June 1992 ] ) Participation another clinical study postmarketing study within last 12 week informed consent History quetiapine therapy current major depressive episode Pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>FK949E</keyword>
	<keyword>Major depressive episode</keyword>
	<keyword>patient</keyword>
</DOC>